Effects of phthalate exposure on asthma may be mediated through alterations in DNA methylation by Wang, I-Jen et al.
Clinical Epigenetics
This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted
PDF and full text (HTML) versions will be made available soon.
Effects of phthalate exposure on asthma may be mediated through alterations in
DNA methylation
Clinical Epigenetics Sample
doi:10.1186/s13148-015-0060-x
I-Jen Wang (wij636@gmail.com)
Wilfried JJ Karmaus (karmaus1@memphis.edu)
Su-Lien Chen (toniachen@genomics.com.tw)
John W Holloway (J.W.Holloway@soton.ac.uk)
Susan Ewart (ewart@cvm.msu.edu)
Sample
 
ISSN 1868-7083
Article type Research
Submission date 15 October 2014
Acceptance date 17 February 2015
Article URL http://dx.doi.org/10.1186/s13148-015-0060-x
Like all articles in BMC journals, this peer-reviewed article can be downloaded, printed and distributed
freely for any purposes (see copyright notice below).
Articles in BMC journals are listed in PubMed and archived at PubMed Central.
For information about publishing your research in BMC journals or any BioMed Central journal, go to
http://www.biomedcentral.com/info/authors/
 
© 2015 Wang et al.; licensee BioMed Central.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
 (2015) 7:27 
Effects of phthalate exposure on asthma may be 
mediated through alterations in DNA methylation 
I-Jen Wang
1,2,3*
 
Email: wij636@gmail.com 
Wilfried JJ Karmaus
4
 
Email: karmaus1@memphis.edu 
Su-Lien Chen
5
 
Email: toniachen@genomics.com.tw 
John W Holloway
6,7
 
Email: J.W.Holloway@soton.ac.uk 
Susan Ewart
8
 
Email: ewart@cvm.msu.edu 
1
 Department of Pediatrics, Taipei Hospital, Ministry of Health and Welfare, 
#127, Su-Yuan Road, Hsin-Chuang Dist 242 New Taipei City, Taiwan 
2
 Institute of Environmental and Occupational Health Sciences, College of 
Medicine, National Yang-Ming University, Taipei 112, Taiwan 
3
 Department of Health Risk Management, China Medical University, Taichung 
404, Taiwan 
4
 Division of Epidemiology, Biostatistics, and Environmental Health, School of 
Public Health, University of Memphis, Memphis 38152, USA 
5
 Genomics, BioSci & Tech, Taipei 221, Taiwan 
6
 Clinical and Experimental Sciences, Faculty of Medicine, and NIHR 
Respiratory Biomedical Research Unit, University of Southampton, Southampton 
S016 6YD, UK 
7
 Human Development and Health, Faculty of Medicine, University of 
Southampton, Southampton SO16 6YD, UK 
8
 Department of Large Animal Clinical Sciences, Michigan State University, East 
Lansing 48824, MI, USA 
Abstract 
Background 
Phthalates may increase the asthma risk in children. Mechanisms underlying this association 
remain to be addressed. This study assesses the effect of phthalate exposures on epigenetic 
changes and the role of epigenetic changes for asthma. In the first step, urine and blood 
samples from 256 children of the Childhood Environment and Allergic diseases Study 
(CEAS) were analyzed. Urine 5OH-MEHP levels were quantified as an indicator of 
exposure, and asthma information was collected. DNA methylation (DNA-M) was measured 
by quantitative PCR. In the screening part of step 1, DNA-M of 21 potential human candidate 
genes suggested by a toxicogenomic data were investigated in 22 blood samples. Then, in the 
testing part of step 1, positively screened genes were tested in a larger sample of 256 children 
and then validated by protein measurements. In step 2, we replicated the association between 
phthalate exposure and gene-specific DNA-M in 54 children in the phthalate contaminated 
food event. In step 3, the risk of DNA-M for asthma was tested in 256 children from CEAS 
and corroborated in 270 children from the Isle of Wight (IOW) birth cohort. 
Results 
Differential methylation in three genes (AR, TNFα, and IL-4) was identified through 
screening. Testing in 256 children showed that methylation of the TNFα gene promoter was 
lower when children had higher urine 5OH-MEHP values (β = −0.138, P = 0.040). 
Functional validation revealed that TNFα methylation was inversely correlated with TNFα 
protein levels (β = −0.18, P = 0.041). In an additional sample of 54 children, we corroborated 
that methylation of the TNFα gene promoter was lower when urine 5OH-MEHP 
concentrations were higher. Finally, we found that a lower methylation of 5′CGI region of 
TNFα was associated with asthma in 256 CEAS children (OR = 2.15, 95% CI = 1.01 to 4.62). 
We replicated this in 270 children from the IOW birth cohort study. Methylation of the CpG 
site cg10717214 was negatively associated with asthma, when children had ‘AA’ or ‘AG’ 
genotype of the TNFα single nucleotide rs1800610. 
Conclusions 
Effects of phthalate exposure on asthma may be mediated through alterations in DNA 
methylation. 
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Background 
In 2011, the Food and Drug Administration (FDA) in Taiwan discovered that manufacturers 
had replaced expensive natural emulsifiers with di-(2-ethylhexyl) phthalate (DEHP) in 
numerous food and drinks for several decades [1]. This ‘contaminated food event’ caused 
uncertainties among the general public and resulted in scientific assessments. Phthalate has 
been described as an endocrine disruptor. Epidemiological studies suggested an association 
between exposure to DEHP and increased prevalence of asthma or wheezing [2-4]. 
Pulmonary physiological data suggests that DEHP may promote and aggravate allergic 
asthma by an adjuvant effect [5]. DEHP is also considered to promote a deviation of Th2 
response (related to allergy) by suppressing IFN-α/IFN-β gene expression and by modulating 
interleukin 4 (IL-4) and immunoglobulin E (IgE) production [6,7]. In an earlier cohort study, 
we demonstrated that exposure to phthalate was positively correlated with serum IgE levels 
with higher risk of atopic disorders in children [8]. In addition, we reported that urine DEHP 
metabolite levels were higher in Taiwanese children compared to US and German children 
[8-10]. 
Animal studies have identified that phthalates, among other endocrine disruptors, may 
modify epigenetic marks [11]. There are numerous reports of epigenetic modifications after 
environmental toxicant exposures, but most have not been directly linked to a disease 
endpoint [11,12]. Although data generated from clinical specimens after environmental 
exposure monitoring are limited, epigenetic changes are considered to mediate associations of 
environmental exposures with asthma [13,14]. This motivated us to investigate potential 
epigenetic effects of phthalate exposures on DNA methylation (DNA-M) and then test the 
effect of the methylation on asthma. In the first step, urine and blood samples from 256 
children of the Childhood Environment and Allergic diseases Study (CEAS) were analyzed. 
In the screening part of step 1, DNA-M of 21 potential human candidate genes suggested by a 
toxicogenomic database due to suspected associations between phthalates and DNA-M were 
screened in 22 blood samples. In the testing part of step 1, three positively screened genes 
were tested in all 256 children and then validated by protein measurements. In step 2, we 
replicated the association between phthalate exposure and gene-specific DNA-M in 54 
children whose parents took them a clinical examination because of DEHP contaminated 
food events in Taiwan in 2011. Urine and blood specimens were analyzed in these children. 
In step 3, the risk of DNA methylation for asthma was tested in 256 children from CEAS and 
corroborated in 270 children from the Isle of Wight (IOW) birth cohort [15] (Figure 1). 
Results from cross-sectional investigation between methylation of multiple genes and asthma 
in the IOW birth cohort have been published elsewhere. We hypothesize that the effect of 
phthalate exposures on asthma is mediated through alterations in DNA methylation. 
Figure 1 Study flow chart. 
  
Results 
Three genes with differential methylation were selected for testing in a larger 
sample 
After screening of 21 candidate genes by quantitative polymerase chain reaction (qPCR) 
(Table 1, Additional file 1: Table S1), differential methylation statuses for high and low 
exposure groups were identified for three genes (androgen receptor (AR), tumor necrosis 
factor α (TNFα), and IL-4). There were no significant differences in 18 other genes (ESR1, 
ESR2, PGR, ESRRG, PPARA, PPARG, THRB, CYP1A1, CYP1B1, CYP19A1, VEGFA, 
MAPK1, MAPK3, STAT3, LIF, NR1I2, LAMP, and TFF1) (Additional file 1: Table S2). The 
three genes were selected for further testing in a larger sample of 256 children. The 
methylation percentages of three candidate genes in 22 samples are presented in Table 1. 
Basic demographic information of the study population is provided in Table 2. With the 
exception of maternal education, there were no significant differences between those with 
complete blood samples (N = 256) and those without (N = 453). 
Table 1 Three candidate genes with differential methylation between low and high DEHP exposure in the screening 
Gene gene ID CpG island location Assay details
b 
TSS position Met%
a (mean ± SD) of low and high DEHP exposure 
AR (androgen receptor) (367) ChrX: 66763684-66764077 Catalog number: 335002 EPHS115070-1A 
SABiosciences CpG Island ID: 115070 
CpG island location: ChrX: 66763684-66764077 
Assay position (central point): ChrX: 66763921 
PCR product size: 171 
NCBI build number: 37 
66763873 Low vs. high exposure: 
    35.73 ± 31.76 vs. 14.95 ± 17.23 
P = 0.071 by qPCR 
TNFα (tumor necrosis factor α) 7124) Chr6: 31543344-31544344 Catalog number: 335002MePH80050-1A 
SABiosciences CpG Island ID: custom design 
CpG island location: Chr6: 31543344-31544344 
Assay position (central point): Chr6: 31543573 
PCR product size: 294 
(The sequence is in the Supplement) 
NCBI build number: 37 
31543350 Low vs. high exposure: 
    42.65 ± 26.36 vs. 35.61 ± 27.13 
P = 0.036 by qPCR 
IL-4 (Interleukin-4) (16189) Chr5: 132035956-132036176 Pyrosequence primer info: 
    F:GTTGATTGGTTTTAAGTGATTGATAATT 
    R:Biotin-ATACCAAATAAATACTCACCTTCTACT 
    S:TTTTTGTTTTTTTTGTTAGTATGT 
Sequence to analysis: 
    GTYGGTAATTTTGTTTAYGGATATAAGTGYGATATTATTTTATAGGAGATTATTA 
132040541 Low vs. high exposure: 
    89.36 ± 3.58 vs. 89.36 ± 7.56 
P = 0.249 by pyrosequencing 
a
Met%: percentage of methylated cytosine in the CGIs; 
b
AR and TNFα results were identified by EpiTect Methyl II qPCR assay. Since there was 
no commercial kit for IL-4 DNA methylation by qPCR, IL-4 results were obtained by pyrosequencing method via QIAGEN PyroMark Q24 
instrument. 
Table 2 Population characteristics 
Category Subjects with urine and blood 
specimens 
Initial cohort with urine 
specimens 
P value 
(N = 256) (N = 453) 
Gender (male) (%) 53.5 57.7 0.31 
Prematurity <37 week (%) 92.1 91.0 0.66 
Maternal age ≥34 years (%) 17.3 17.8 0.89 
Maternal history of atopy (%Yes) 42.6 35.1 0.10 
Maternal education ≥ college (%) 40.3 30.8 0.03* 
Breast feeding (%Yes) 79.8 76.4 0.39 
ETS exposure (%Yes) 40.3 46.2 0.10 
Family income per year >1,500,000 (NT dollars) (%) 8.7 8.0 0.33 
Asthma (%Yes) 25.4 26.9 0.89 
*P<0.05. 
Inverse association of TNFα methylation status with exposure in a larger 
sample 
In a larger sample of 256 children, the levels of the geometric means (standard deviations 
(SDs)) of 5OH-MEHP, MEP, MBP, and MBzP were 6.80 (3.40), 14.29 (3.87), 5.49 (3.95), 
and 0.70 (3.04) ng/mL, respectively. After adjusting for confounders, the methylation of the 
5′CGI region of the TNFα gene was inversely associated with Ln-5OH-MEHP (β = −0.138, P 
= 0.040) and Ln-MBzP (β = −0.144, P = 0.032) (Table 3). Since both Ln-5OH-MEHP and 
Ln-MBzP were correlated (Spearman’s r = 0.139, P = 0.027) and 5OH-MEHP presents a 
high fraction of the metabolites, we decided to focus on 5OH-MEHP. The association of AR 
methylation percentage with Ln-5OH-MEHP levels and IL-4 methylation percentage with 
Ln-5OH-MEHP levels failed to reach a level of statistical significance after adjusting for 
urine creatinine, white blood cell proportion, gender, age, maternal education, and 
environmental tobacco smoke exposure (β = −0.103, P = 0.237; β = −0.217, P = 0.147, data 
not shown). 
Table 3 The association of log-transformed urine phthalate levels and standardized 
regression coefficients βeta for TNFα methylation 
Urine phthalate 
metabolites
b
 
Ln-
MEP 
P 
value 
Ln-
MBP 
P 
value 
Ln-
MBzP 
P 
value 
Ln-5OH-
MEHP 
P 
value 
TNFα (Met%) 
Crude β −0.009 0.887 −0.057 0.367 −0.154 0.014* −0.175 0.005* 
Adjusted βa −0.045 0.508 −0.044 0.534 −0.144 0.032* −0.138 0.040* 
MEP, monoethyl phthalate; MBP, monobutyl phthalate; MBzP, monobenzyl phthalate; 5OH-MEHP, 
mono(2-ethyl-5-hydroxyhexyl)phthalate; Met%, methylation percentage. aAdjustment for urine 
creatinine, white blood cell proportion, gender, age, maternal education, and environmental tobacco 
smoke exposure; bThe main urine phthalate metabolite levels measured in this study included MEP, 
MBP, MBzP, and 5OH-MEHP.*P < 0.05. 
To validate whether the TNFα 5′CGI methylation status affects its protein production, we 
analyzed plasma TNFα protein level in 256 children. The mean level was 901.78 pg/mL (SD: 
11.51 pg/mL). We found that TNFα protein level was inversely associated with TNFα 
methylation percentage (β = −0.18, P = 0.041; Additional file 1: Figure S2). 
Phthalate-methylation associations in a clinical sample 
To test if the association between phthalate exposure and DNA methylation identified in the 
high exposure cohort, we evaluated the correlation between TNFα methylation and 5OH-
MEHP level in 54 children who attended a clinic due to phthalate-contaminated food event. 
In these children, the geometric mean level of 5OH-MEHP was 9.51 ng/mL (SD: 6.47 
ng/mL). TNFα methylation percentage showed an inverse association with 5OH-MEHP level 
(β = −0.246, P = 0.168), though it failed to reach statistical significance. 
Phthalate exposure was positively associated with asthma 
To test the association of phthalates with asthma, the cohort of 256 children were divided into 
three groups based on tertiles of urine 5OH-MEHP levels. After adjusting for gender, age, 
prematurity, maternal history of atopy, maternal education, and environmental tobacco smoke 
exposure, urine 5OH-MEHP levels were significantly associated with asthma (OR = 2.17, 
95% CI = 1.03 to 4.56) for the highest tertile (>19.33 ng/mL) compared with the lowest 
tertile (<4.14 ng/mL; Table 4). There was no significant association between MBzP and 
asthma. 
Table 4 The association of phthalate exposure with asthma in children 
Urine 5OH-MEHP levels (ng/mL) Subjects Asthma Non-asthma OR Adjusted OR
a 
(N = 256) (N = 56) (N = 200) (95% CIs) (95% CIs) 
>19.33 54 18(32.1) 36(18.0) 2.30(1.15 to 4.63)* 2.17(1.03 to 4.56)* 
4.14 to 19.33 45 10(17.9) 35(17.5) 1.12(0.58 to 2.97) 1.29(0.54 to 3.06) 
<4.14 157 28(50.0) 129(64.5) 1 1 
a
Adjustment for gender, age, prematurity, maternal history of atopy, maternal education, and 
environmental tobacco smoke exposure. *P<0.05. 
Lower methylated TNFα 5′CGI was associated with asthma 
To analyze the association of TNFα 5′CGI methylation with asthma in CEAS cohort, we first 
compared mean methylation levels. A lower TNFα methylation percentage was found in 
children with asthma (mean ± SD: 31.53 ± 25.96%) in contrast to children without (41.14 ± 
26.88%, P = 0.018). For logistic regression analysis, we dichotomized the methylation into 
low and high. After adjusting for gender, age, prematurity, maternal history of atopy, 
maternal education, and environmental tobacco smoke exposure, TNFα 5′CGI of children in 
the lower methylated group were found to be positively associated with asthma (OR = 2.15, 
95% CI = 1.01 to 4.62) compared to the higher methylated group (Table 5). 
Table 5 The association of TNFα 5′CGI methylation status and asthma in children 
 Asthma Non-asthma Subjects OR Adjusted OR
b 
(N = 56) (N = 200) (N = 256) (95% CIs) (95% CIs) 
Lower methylated TNFα 5′CGIa 35(62.5) 93(46.5) 128(50.0) 1.92(1.04 to 3.52)* 2.15(1.01 to 4.62)* 
Higher methylated 21(37.5) 107(53.5) 128(50.0) 1 1 
aTNFα methylation status was dichotomized into lower and higher methylated group with cutoff value 
of median of promoter methylation percentage; 
b
Adjustment for gender, age, prematurity, maternal 
history of atopy, maternal education, and environmental tobacco smoke exposure. *P<0.05. 
To test whether findings regarding DNA-M and asthma could be replicated, we used DNA 
methylation data available from the IOW UK birth cohort. We identified three cytosine-
phosphate-guanine sites (CpGs) within the Illumina Infinium HumanMethylation450 
BeadChips data of the IOW birth cohort that were included in the PCR product sequence of 
the TNFα methylation in the Taiwanese study (cg04425624, cg10717214, and cg10650821). 
Since the Taiwanese and the UK children have different genetic backgrounds, we 
additionally tested the TNFα single nucleotide polymorphism (SNP) rs1800610, an asthma 
candidate SNP. The interaction of the SNP rs1800610 and methylation of cg10717214 on risk 
of asthma showed a statistically significant effect. When the methylation level of cg10717214 
was low and the genotype was AA or AG, the relative risk (RR) of asthma was higher (8% 
methylation: RR = 4.28, P = 0.008; 10% methylation: RR = 2.25, P = 0.015, Additional file 
1: Figure S3). 
Does TNFα 5′CGI methylation link phthalate exposure with asthma? 
Our study design initiated from phthalate exposure and tested potential changes in DNA 
methylation. The association of phthalate exposure and TNFα 5′CGI methylation with asthma 
was assessed in the last step. This flow of assessments protected us from reverse causation, 
namely that phthalate exposure and the methylation of the 21 candidate genes resulted from 
different immune and metabolic responses related to asthma. 
In addition, to estimate whether TNFα 5′CGI methylation is an intervening variable between 
5OH-MEHP and asthma, we conducted a mediation analysis. The mediation analyses 
incorporated the different regression coefficients (5OH-MEHP and TNFα 5′CGI, Additional 
file 1: Figure S4). It is estimated that 20% of the total effect of 5OH-MEHP on asthma is 
mediated by TNFα 5′CGI. 
Discussion 
This is the first epidemiological study linking phthalate exposure with DNA methylation and 
asthma in humans. We demonstrated that higher exposure to phthalates is related to lower 
DNA methylation of TNFα, which in turn is associated with higher risk of asthma in children. 
In addition, we showed that the protein levels of TNFα were inversely related to phthalate 
exposures. The association between phthalate exposures and TNFα methylation was 
replicated in another 54 children who attended a clinic due to a phthalate contaminated food 
event. The role of DNA methylation of TNFα with asthma was further replicated in the Isle of 
Wight birth cohort for children with a specific TNFα polymorphism. In addition, a mediation 
analysis demonstrated that TNFα 5′CGI may be a potential epigenetic link between phthalate 
and asthma. 
We chose 5OH-MEHP as an indicator of DEHP exposure because it represents high fraction 
of all metabolites. In addition, we replicated our findings in another sample of children in the 
DEHP contaminated food event. TNFα methylation percentage in this group also showed an 
inverse correlation with 5OH-MEHP level. These findings support our hypothesis that 
phthalate exposure may affect TNFα methylation. DEHP has been demonstrated to induce 
TNFα release and macrophage differentiation in murine monocyte-macrophage cell line [16]. 
The study by Lee et al. indicates that DEHP-induced allergy-related cytokine (IL-4 and 
TNFα) production by human mast cell line-1 cells [17]. Win-Shwe et al. reported that 
exposure to DEHP may up-regulate TNFα mRNA expression levels in mice [18]. Further, 
dendritic cells treated with endocrine disrupters were reported to increase TNFα expression 
and epigenetic change at the TNFα gene locus [19]. In the screening, we also found that AR 
methylation was weakly related to phthalate exposure (P = 0.071). However, in the large 
sample, AR failed to display significant differences in methylation after adjusting for 
potential confounders. Since different cell types of white blood cells might be responsible for 
the DNA methylation changes, we have adjusted white blood cell proportion in the model to 
exclude the confounding effect. However, we did not conduct differential blood cell counts or 
flow cytometry. Hence, we have no data on whether specific white blood cells were highly 
methylated and established the link with asthma. 
A lower methylation of TNFα 5′CGI was positively associated with asthma. Moreover, TNFα 
methylation and TNFα protein levels tested in 256 children showed an inverse relationship. 
Hence, high phthalate exposure might lead to lower methylation of TNFα 5′CGI, which in 
turn is associated with increased protein production. We speculate that an increased TNFα 
protein levels may trigger the development of allergic inflammation. TNFα has been 
implicated in airway inflammation and hyperresponsiveness and the regulation of immune 
cells, hallmark features of asthma [20]. It may also up-regulate the high affinity IgE receptor 
and IgE-dependent activation of airway smooth muscle cells [21]. Genetic variants of TNFα 
have been associated with development of asthma, total serum IgE level in asthma patients, 
and severity of asthma [22,23]. We believe that better understanding of the mechanism of 
TNFα methylation after environmental exposures may shed new light on improved 
therapeutic strategies for asthma. 
There are some limitations of this study. First, our study was limited by the use of a 
toxicogenomic-based candidate gene approach. The candidate gene approach was based on 
the prior knowledge about functional aspects of possible candidates, which may lead to an 
information bottleneck. However, instead of only one candidate gene, we selected 21 
candidate genes from a published toxicogenomic database for screening and validation. 
Although this approach adds to biological plausibility to our study and is more cost-effective 
than the epigenome-wide approach, we did not conduct a systematic screening of all genes 
that are potentially affected by phthalate exposure. However, our results demonstrate 
agreement between TNFα methylation and its protein expression. This further supports the 
role of this newly discovered epigenetic marker. Second, we did not conduct a systematic 
approach of all CpG sites in the 21 genes but focused on qPCR method of CpG islands in 
promoter regions. Hence, we cannot exclude that other CpG sites and CpG of additional 
genes are involved linking phthalate exposure and asthma. Second, we did not investigate 
whether the methylation of the 21 genetic candidates could have affected by methylation 
quantitative loci. Third, we did not correct the analysis by multiple comparisons because the 
sample size was not large enough. However, we repeated the findings in two independent 
samples. For the phthalate body burden, we used another group of children from Taiwan. For 
the association of DNA methylation with asthma, we used a cohort of British children. The 
ability to repeat the analyses in two independent samples establishes a higher burden than 
adjusting for multiple testing. Fourth, our measurements are based on a single early morning 
urine sample only. However, spot urine samples and 24-h urine samples produced 
comparable estimates of daily DEHP intake [24]. Even though phthalates have relatively 
short half-lives, continuous daily exposure results in an exposure scenario that is similar to 
persistent and bioaccumulative compounds [25]. In addition, if measurement errors occurred, 
they tend to be towards the null and the effect of exposure would likely to be underestimated. 
Fifth, we used a cross-sectional design and cannot exclude reverse causation, namely that 
asthma influences DNA methylation. However, the analytical approach starting with 
phthalate exposure, followed by an assessment of the exposure-selected effect of DNA 
methylation on asthma, minimizes the bias of reverse causation. In addition, we estimated the 
mediating effect of DNA methylation. 
One of the strengths of this study is that we used biological specimens to link clinical and 
environmental exposure data. The use of urine biomarkers analyzed by ultra-performance 
liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) offered a 
more direct measure of individual exposure than house dust by integrating ingestion, 
inhalation, and dermal absorption. Furthermore, asthma was determined by pediatricians 
instead of by questionnaire alone. Therefore, the misclassification of asthma is low and not 
related to exposure. Another strength is that we applied a three-step approach: a qPCR 
method to identify candidate gene methylation and followed by confirming the candidate 
gene methylation status in a large sample. Finally, we replicated our findings in two 
independent pediatric populations. This step-wise approach allowed us to detect the most 
promising candidates cost-effectively. 
Conclusions 
In conclusion, we found that phthalate exposures are associated with DNA methylation and 
that methylation of TNFα in turn is associated with asthma. TNFα 5′CGI may be a potential 
epigenetic biomarker for phthalate-induced asthma. Our results contribute to the 
understanding of the etiology of phthalate-related asthma and may initiate new strategies for 
early prevention or therapeutic intervention in children exposed to phthalates. 
Methods 
Study population 
In 2010, in Taipei, a total of 256 children from CEAS cohort were recruited and urine and 
blood specimens were collected. Full enrollment into the study required the completion of 
phthalate exposure monitoring by checking urine phthalate metabolite levels and blood 
sampling. Parents were interviewed using a standardized questionnaire in the pediatric clinics 
on birth history, parental age education levels, parental atopy, child environmental exposures, 
diet habits, and allergic diseases. Written informed consent was obtained from parents. The 
study protocol was approved by the Institutional Review Board from Taipei Hospital, 
Ministry of Health and Welfare, and complied with the principles outlined in the Helsinki 
Declaration. 
The replication study included 94 male and 196 female participants, age 18 years of the IOW 
birth cohort study, who had DNA-M measured at age 18 years, and information on the TNFα 
SNP rs1800610, asthma at age 18, birth order, and duration of breastfeeding [26]. 
Determination of cases 
In the CEAS cohort, pediatric allergists performed a standardized history and clinical 
examination on participants at age 3. Asthma was determined by pediatric allergists based on 
the following three criteria: (i) recurrence of at least two of the three symptoms: cough, 
wheeze, and shortness of breath within the previous 12 months, (ii) doctor’s diagnosis of 
asthma with ongoing treatment, and (iii) response to treatment with β2-agonists or inhaled 
corticosteroids [27]. In the IOW birth cohort, asthma was defined as having ‘ever had 
asthma’ and either ‘wheezing or whistling in the chest during the previous 12 months’ or 
‘current treatment for asthma’. 
Laboratory methods 
Exposure monitoring 
Urine phthalate metabolite levels (5OH-MEHP, MEP, MBP, and MBzP) were measured by 
UPLC-MS/MS, as described elsewhere [28]. 5OH-MEHP in urine, the major metabolite of 
DEHP, was used to approximate exposure. 5OH-MEHP levels below the limit of 
quantification were imputed as 1.36 ng/mL. 
gDNA isolation and purification 
The gDNA was isolated and purified from the whole blood with the QIAGEN Puregene 
Blood Kit (QIAGEN #158389, QIAGEN, Inc., Valencia, CA, USA). The DNA quality was 
measured with spectrophotometer and gel electrophoresis. 
Detection of DNA methylation by pyrosequencing 
The bisulfate conversion of DNA was treated with EpiTect® Plus Bisulfite Conversion K it 
(QIAGEN #59124, QIAGEN, Inc., Valencia, CA, USA). We also used the reference DNA set 
(included unmethylated DNA and methylated DNA) (QIAGEN #59695, QIAGEN, Inc., 
Valencia, CA, USA) to monitor the bisulfate conversion efficiency. 
The assays were designed by QIAGEN PyroMark Assay Design v2.0 software (QIAGEN, 
Inc., Valencia, CA, USA). The primer sequence of these assays is listed in the Table 1 and 
Additional file 1: Table S2. 
The PCR reaction composition using PyroMark PCR Kit (QIAGEN #978703, QIAGEN, Inc., 
Valencia, CA, USA) are HotStarTaq DNA Polymerase, 1× PyroMark PCR Buffer, dNTPs, 
1× CoralLoad, 3 mM MgCl2, 0.2 uM Primers, 1× Q-solution, and 20 ng bisulfate-converted 
DNA. The PCR program was performed by the Veriti Thermo Cycler (Life Technology # 
4375786, Life Technologies, Carlsbad, CA, USA). The PCR products were checked with gel 
electrophoresis. 
The PCR products were separated into single strands using streptavidin-coated beads. Add 
PyroMark Gold Q24 Reagents (QIAGEN #970802, QIAGEN, Inc., Valencia, CA, USA) into 
QIAGEN Cartridge. The sequence signals were generated by PyroMark Q24 instrument and 
analyzed the sequence peak signal intensity by PyroMark Q24 software v2.0.6. 
Detection of DNA methylation by real-time PCR 
Restriction digestion was performed using the EpiTect Methyl II DNA Restriction Kit (SAB# 
335452). Each sample was divided into four tubes and treated with methylation-sensitive 
(Ms) restriction enzyme, methylation-dependant(Md) restriction enzyme, Ms + Md, and a 
mock (no enzymes added), respectively (Additional file 1: Figure S5). Reference DNA sets 
(included unmethylated DNA and methylated DNA) (QIAGEN #59695, QIAGEN, Inc., 
Valencia, CA, USA) were used to monitor the enzyme digestion efficiency. Following 
digestion, the remaining DNA in each individual enzyme reaction was quantified by ViiA7 
real-time PCR instrument. The assay primers were designed and synthesized by QIAGEN 
SABioscience (QIAGEN, Inc., Valencia, CA, USA). The assay primers information is listed 
in Table 1 and Additional file 1: Table S2. The PCR cycling protocol is 95 C, 10 min, repeat 
3 cycles of (99 C, 30 s → 72°C, 1 min), and then repeat 40 cycles of (97 C, 15 s, 72 C, 1 min, 
and detect fluorescence}. The relative fractions of methylated and unmethylated DNA are 
subsequently determined by comparing the amount in each digest with that of a mock (no 
enzymes added) digest using a ΔCT method. Download the EpiTect Methyl PCR Array 
Excel-based data analysis template 
(www.sabiosciences.com/dna_methylation_data_analysis.php). Then, paste in the CT value 
data and analyze the automatically generated results by following the directions in the 
‘Instructions’ worksheet of the Excel file. 
Step 1: screening of candidate genes and testing of differential methylation 
status by qPCR of selected genes in a larger sample 
Twenty-one human candidate genes (ESR1, ESR2, AR, PGR, ESRRG, PPARA, PPARG, 
THRB, CYP1A1, CYP1B1, CYP19A1, VEGFA, MAPK1, MAPK3, STAT3, LIF, NR1I2, 
LAMP, TFF1, TNFα, and IL-4) whose methylation at CpG islands (CGI)s may be related to 
phthalates based on a toxicogenomic database were selected [11,29]. The selection was based 
on the following criteria: (i) report to be related with DEHP in human studies and (ii) report 
to have an association with asthma. Figure 1 shows the study flow chart for selecting 
candidate genes. Initially, we analyzed DNA samples of 11 age and gender-matched children 
with the highest 5OH-MEHP levels in the cohort (high exposure group, 5 with and 6 without 
asthma) and 11 age and gender-matched children of the lowest 5OH-MEHP levels (low 
exposure group, 5 with and 6 without asthma). Twenty-two blood samples from 256 cohort 
children were screened by EpiTect Methyl II qPCR to assess the differential methylation 
between high and low exposure group (Table 1, Additional file 1: Table S2). The qPCR 
method is based on the detection of remaining input DNA after cleavage with a methylation-
dependent restriction enzyme (Additional file 1: Figure S5) [30]. For those genes that did not 
have commercial kits for qPCR, we checked methylation status by pyrosequencing method 
via QIAGEN PyroMark Q24 instrument (QIAGEN, Inc., Valencia, CA, USA) [31]. 
Candidate genes with differential methylation were further tested in a larger sample of 256 
cohort children. Then, we functionally validated candidate gene expression by measuring 
protein levels using ELISA. The association between candidate genes methylation status, 
exposure levels, and asthma was evaluated. 
Step 2: replicating the phthalate-methylation association in a clinical sample 
To investigate whether we can replicate the association between phthalate exposure and the 
identified gene methylation, we enrolled another sample of 54 children, who were presented 
by their parents in the clinic because of DEHP contaminated food events whose urine and 
blood samples were available. 
Step 3: testing the association between gene methylation and asthma in children 
from CEAS and IOW birth cohort 
A whole population birth cohort was established in the Isle of Wight, UK, in 1989 to 
prospectively study the natural history and etiology of asthma, eczema, and allergic 
conditions. A total of 1,456 children were followed up at 1, 2, 4, 10, and 18 years, as 
described elsewhere [15]. Blood or saliva samples were collected at the ages of 10 and 18 
years for genetic analysis. 
In the IOW cohort, DNA was measured using Illumina Infinium HumanMethylation450 
BeadChips (Illumina, Inc., San Diego, CA, USA), as previously described [15]. The TNFα 
SNPs rs1800610 (an intron variant) was determined using Golden Gate Genotyping Assays 
(Illumina, Inc., San Diego, CA, USA) on the Bead Xpress Veracode platform (Illumina, Inc., 
San Diego, CA, USA). In brief, samples were fragmented and hybridized to the pool of 
allele-specific primer sets. Following an extension/ligation reaction, the samples were then 
hybridized to the Veracode bead pool and processed on the BeadXpress reader. Data were 
analyzed using the genotyping module of the GenomeStudio software package (Illumina, 
Inc., San Diego, CA, USA). The quality threshold for allele determination was set at a 
GenCall score 0.25 (scores #0.25 were ‘no calls’) with 98.3% and retained for further 
analysis. 
Statistical analysis 
For statistical purposes, the concentration of 5OH-MEHP was log-transformed and also 
categorized into three exposure groups. Independent t-tests were performed to assess 
differences of methylation percentage (Met%: the percentage of methylated cytosine in the 
CGIs) between high and low exposure groups. The relationships between phthalate 
metabolite levels and TNFα promoter Met% and between Met% and TNFα protein expression 
levels were evaluated by linear regression. To evaluate the association of methylation status 
with asthma, we used logistic regression analyses and provided odds ratios and their 94% 
confidence limits. Selection of the confounders that were left in the model was based on the 
literature and the 10% rule of thumb of keeping a potential confounder in a model when 
removal changes the association of exposure and outcomes by more than 10%. All tests 
assumed a two-sided alternative hypothesis and a 0.05 significance level. All analyses were 
conducted using SAS software version 9.1 (SAS Institute, Cary, NC, USA). 
In the IOW birth cohort, after cleaning the DNA-M data, beta (β) values are presented as the 
proportion of intensity of methylated (M) over the sum of methylated (M) and unmethylated 
(U) sites (β = M/[c + M + U] with c being a constant to prevent dividing by zero) were used 
to estimate the effect of DNA methylation [32]. The EpiTect Methyl II qPCR to measure 
methylation of TNFα (Chr6: 31543344–31544344) includes 11 CpG sites, of which 8 CpGs 
were also measured Illumina Infinium HumanMethylation450 BeadChip (Illumina, Inc., San 
Diego, CA, USA). Two of these did not pass quality control, three were disqualified due to 
probe SNPs, and three could be taken into consideration. Since we were comparing a 
Taiwanese sample with a sample from the UK, we took genetic difference into account. To 
this end, we estimated the statistical interaction between the TNFα SNPs rs1800610 and 
methylation level of cg10717214, cg04425624, and cg10650821 on the risk for asthma at age 
18 years. In log-linear models, we estimated the interaction on a multiplicative scale. 
Statistically, we controlled for sex of the child, birth order, and duration of breastfeeding 
(weeks). 
To evaluate how much risk of asthma in relation to exposure to phthalate is explained by 
changes in DNA methylation in TNFα gene, we conducted a mediation analysis [33]. The 
mediation analyses incorporated the different regression coefficients (exposure: 5OH-MEHP, 
mediator: TNFα 5′CGI, and outcome: asthma). The mediation proportions, the percentage 
change of the regression coefficients when we include an intermediate variable in the model, 
were calculated (Additional file 1: Figure S4). Both logistic and linear regressions were used. 
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